Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Approach for Oligospermia (NAPO): A Randomized Controlled Trial

NCT06300229 is registered in ClinicalTrials.gov with Martin Blomberg Jensen as lead sponsor.

NCT NCT06300229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06300229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Approach for Oligospermia (NAPO): A Randomized Controlled Trial
Lead sponsor
Martin Blomberg Jensen
Phase
Phase 1/2
Overall status
Completed
Start date
March 1, 2024
Completion date
August 31, 2025
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infertility, male